CLINICAL COURSE OF LABOUR IN WOMEN WITH NON-ALCOHOLIC STEATOHEPATITIS AGAINST THE BACKGROUND OF OBESITY OF VARIOUS DEGREES

Authors

DOI:

https://doi.org/10.11603/24116-4944.2022.2.13482

Keywords:

non-alcoholic steatohepatitis, obesity, labour complications, non-invasive diagnostics

Abstract

The aim of the study – to evaluate the clinical course of delivery in women with non-alcoholic steatohepatitis against the background of obesity of various degrees.

Materials and Methods. We examined 98 pregnant women with nonalcoholic steatohepatitis (NASH) in combination with obesity. The control group consisted of 30 practically healthy pregnant women. All pregnant women are divided into 3 groups depending on the body mass index (BMI): IA group – 26 patients with a BMI of 25–29.9 kg/m², IB group – 48 pregnant women with a BMI of 30–34.9 kg/m², IC group – 24 pregnant women with a BMI of 35–39.9 kg/m². To assess the presence and severity of steatosis and steatohepatitis, liver elastography with steatometry and the non-invasive test NASH-FibroTest were performed.

Results and Discussion. During the analysis of the course of childbirth, preterm labour was observed in the IA group 1.7 times, in the IB group 2.5 times, in the IC group 3.1 times more often than in the control group (p<0.05), primary . labor weakness occurred 1.1 times more often in the IA group, 3.1 times in the IB group, and 3.7 times more often in the IC group than in the control pregnant group (p<0.05). Postpartum bleeding developed in patients of group IA 2.3 times, group IB – 3.7 times, and group IC – 5.0 times more than in pregnant control groups (p<0.05), and a clinically narrow pelvis . was diagnosed in women with increased body weight 3.8 times more often, in pregnant women with obesity of the first degree 6.2 times, and in patients with obesity of the II–III degree 8.3 times more often than in the control group (p<0.05).

Conclusions. The clinical course of delivery in a parturient with NASH on the background of obesity is accompanied by a significantly higher frequency of obstetric and perinatal complications, which are positively correlated with BMI growth and indicate the severity of NASH during pregnancy.

References

EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease. (2016). Journal of Hepatology, 64(6), 1388-1402. DOI: 10.1016/j.jhep.2015.11.004.

Francque, S.M., Marchesini, G., Kautz, A., Walmsley, M., Dorner, R., Lazarus, J.V., Zelber-Sagi, S., … & Lionis, C. (2021). Non-alcoholic fatty liver disease: A patient guideline. JHEP Reports: Innovation in Hepatology, 3(5), 100322. DOI: 10.1016/j.jhepr.2021.100322.

Younossi, Z.M., Marchesini, G., Pinto-Cortez, H., & Petta, S. (2019). Epidemiology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis. Transplantation, 103(1), 22-27. DOI: 10.1097/tp.0000000000002484.

Ministry of Health of Ukraine (2014). Pro zatverdzhen-nia ta vprovadzhennia medyko-tekhnolohichnykh dokumentiv zi standartyzatsii medychnoi dopomohy pry khronichnykh neinfektsi-inykh hepatytakh № 826 [On approval and implementation of medical and technological documents standardizing medical care of chronicnon-infectious hepatitis No. 826]. Retrieved from: https://ips.ligazakon.net/document/MOZ24038?ed=2014_11_06&an=19.

Lefere, S., & Tacke, F. (2019). Macrophages in obesity and non-alcoholic fatty liver disease: Crosstalk with metabolism. JHEP Reports, 1(1), 30-43. DOI: 10.1016/j.jhepr.2019.02.004.

Friedman, S.L., Neuschwander-Tetri, B.A., Rinella, M., & Sanyal, A.J. (2018). Mechanisms of NAFLD development and therapeutic strategies. Nature Medicine, 24(7), 908-922. DOI: 10.1038/s41591-018-0104-9.

Mousa, N., Abdel-Razik, A., Shams, M., Sheta, T., Zakaria, S., Shabana, W., Effat, N., … & Eldars, W. (2018). Impact of non-alcoholic fatty liver disease on pregnancy. British Journal of Biomedical Science, 75(4), 197-199. DOI: 10.1080/09674845.2018.1492205.

Lee, Y.W., & Yarrington, C.D. (2017). Obstetric Outcomes in Women with Nonalcoholic Fatty Liver Disease. Metabolic Syndrome and Related Disorders, 15(8), 387-392. DOI: 10.1089/met.2017.0058.

Ram, M., Berger, H., Lipworth, H., Geary, M., McDonald, S.D., Murray-Davis, B., Riddell, C., … & Melamed, N. (2019). The relationship between maternal body mass index and pregnancy outcomes in twin compared with singleton pregnancies. International Journal of Obesity, 44(1), 33-44. DOI: 10.1038/s41366-019-0362-8.

Zhang, Y., Wang, Z.-L. ., Liu, B., & Cai, J. (2014). Pregnancy outcome of overweight and obese Chinese women with gestational diabetes. Journal of Obstetrics and Gynaecology, 34(8), 662-665. DOI: 10.3109/01443615.2014.920787.

Subichin, M., Clanton, J., Makuszewski, M., Bohon, A., Zografakis, J.G., & Dan, A. (2015). Liver disease in the morbidly obese: a review of 1000 consecutive patients undergoing weight loss surgery. Surgery for Obesity and Related Diseases, 11(1), 137-141. DOI: 10.1016/j.soard.2014.06.015.

Koehler, E.M., Plompen, E.P.C., Schouten, J.N.L., Hansen, B.E., Darwish Murad, S., Taimr, P., Leebeek, F.W.G., Hofman, A., Stricker, B.H., Castera, L., & Janssen, H.L.A. (2015). Presence of diabetes mellitus and steatosis is associated with liver stiffness in a general population: The Rotterdam study. Hepatology, 63(1), 138-147. DOI: 10.1002/hep.27981.

Melchor, I., Burgos, J., Del Campo, A., Aiartzaguena, A., Gutiérrez, J., & Melchor, J.C. (2019). Effect of maternal obesity on pregnancy outcomes in women delivering singleton babies: a historical cohort study. Journal of Perinatal Medicine, 47(6), 625-630. DOI: 10.1515/jpm-2019-0103.

Hershman, M., Mei, R., & Kushner, T. (2019). Implications of Nonalcoholic Fatty Liver Disease on Pregnancy and Maternal and Child Outcomes. Gastroenterol Hepatology (NY), 15(4), 221-228. Retrieved from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6696596/.

Avcı, M.E., Şanlıkan, F., Çelik, M., Avcı, A., Kocaer, M., & Göçmen, A. (2014). Effects of maternal obesity on antenatal, perinatal and neonatal outcomes. J. Matern. Fetal. Neonatal. Med., 28(17), 2080-2083. DOI: 10.3109/14767058.2014.978279.

Masuoka, H.C., & Chalasani, N. (2013). Nonalcoholic fatty liver disease: an emerging threat to obese and diabetic individuals. Ann. NY Acad. Sci., 1281(1), 106-122. DOI: 10.1111/nyas.12016.

Chalasani, N., Younossi, Z., Lavine, J.E., Charlton, M., Cusi, K., Rinella, M., Harrison, S.A., Brunt, E.M., & Sanyal, A.J. (2017). The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases. Hepatology, 67(1), 328-357. DOI: 10.1002/hep.29367.

Geier, A., Rinella, M.E., Balp, M.M., McKenna, S.J., Brass, C.A., Przybysz, R., Cai, J., … & Ratziu, V. (2021). Real-World Burden of Nonalcoholic Steatohepatitis. Clinical Gastroenterology and Hepatology : The Official Clinical Practice Journal of The American Gastroenterological Association, 19(5), 1020-1029.e7. DOI: 10.1016/j.cgh.2020.06.064.

Echeverria, C., Eltit, F., Santibanez, J.F., Gatica, S., Cabello-Verrugio, C., & Simon, F. (2020). Endothelial dysfunction in pregnancy metabolic disorders. Biochim. Biophys. Acta. Mol. Basis Dis., 1866(2), 165414. DOI: 10.1016/j.bbadis.2019.02.009.

Westbrook, R.H., Dusheiko, G., & Williamson, C. (2016). Pregnancy and liver disease. J. Hepatol., 64(4), 933-945. DOI: 10.1016/j.jhep.2015.11.030.

Hagström, H., Höijer, J., Ludvigsson, J.F., Bottai, M., Ekbom, A., Hultcrantz, R., Stephansson, O., & Stokkeland, K. (2015). Adverse outcomes of pregnancy in women with non-alcoholic fatty liver disease. Liver International, 36(2), 268-274. DOI: 10.1111/liv.12902.

Published

2022-12-15

How to Cite

Bahniy, L. V. (2022). CLINICAL COURSE OF LABOUR IN WOMEN WITH NON-ALCOHOLIC STEATOHEPATITIS AGAINST THE BACKGROUND OF OBESITY OF VARIOUS DEGREES. Actual Problems of Pediatrics, Obstetrics and Gynecology, (2), 119–128. https://doi.org/10.11603/24116-4944.2022.2.13482

Issue

Section

OBSTETRICS AND GYNECOLOGY